Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Sareum Holdings ( (GB:SAR) ) is now available.
Sareum Holdings PLC has successfully raised £1.07 million through an institutional equity fundraise by issuing 8,560,000 new ordinary shares at a price of 12.5 pence each, which is a 24% discount to the previous day’s closing price. The funds will be used to support the development of Sareum’s expanded portfolio, including SRA737, and for general working capital, potentially enhancing the company’s market position and shareholder value.
More about Sareum Holdings
Sareum Holdings PLC is a clinical-stage biotechnology company based in Cambridge, UK. It specializes in developing next-generation kinase inhibitors aimed at treating autoimmune diseases and cancer.
YTD Price Performance: -32.65%
Average Trading Volume: 180,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £20.61M
For an in-depth examination of SAR stock, go to TipRanks’ Stock Analysis page.